MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    BST1 rs4698412 allelic variant increases the risk of gait or balance deficits in patients with Parkinson’s disease

    Y. Shen, J. Wang, K. Zhang (Nanjing, China)

    Objective: We aimed to explore effects of bone marrow stromal cell antigen‐1 (BST1) rs4698412 allelic variant on brain activation and associative clinical symptoms in Parkinson’s…
  • 2019 International Congress

    Exercise and physical activity for people with Progressive Supranuclear Palsy

    S. Slade, D. Finkelstein, J. Mcginley, M. Morris (Ivanhoe, Australia)

    Objective: To (i) evaluate the literature on exercise and physical activity for Progressive Supranuclear Palsy and (ii) make PSP-specific recommendations for exercise programs and trial…
  • 2019 International Congress

    The congruence of asymmetry between motor symptoms and retinal thickness in Parkinson’s disease

    W. Suh, JY. Hong, SY. Kang (Wonju, Republic of Korea)

    Objective: To analyze the relationship between interocular difference of retinal thickness and motor asymmetry in Parkinson’s disease (PD). Background: It is known that the early…
  • 2019 International Congress

    Deep mitochondrial sequencing in Parkinson’s disease reveals possible genetic modifiers of reduced penetrance in Parkin/PINK1 mutation carriers

    J. Trinh, A. Hicks, K. Wasner, M. Farrer, F. Hentati, P. Bauer, S. Imhoff, K. Kandaswamy, N. Ouzren, M. Werber, A. Rolfs, V. Kostic, A. Lang, P. Pramstaller, P. Seibler, K. Lohmann, A. Gruenewald, C. Klein (Luebeck, Germany)

    Objective: To discover potential penetrance biomarkers in mitochondrial DNA (mtDNA) for Parkin and PINK1 mutation carriers. Background: Biallelic mutations in Parkin and PINK1 are fully…
  • 2019 International Congress

    Freezing of gait as a reflection of disturbed general time processing in Parkinson’s disease? A new look on a complex phenomenon

    J. Wagner, A. Gulberti, J. Verrel, S. Tunc, T. Bäumer, W. Hamel, AK. Engel, C. Gerloff, CKE. Moll, A. Münchau, M. Pötter-Nerger (Hamburg, Germany)

    Objective: The aim of the study is to assess the association of freezing of gait (FoG) with disturbed time processing in Parkinson´s disease (PD) by…
  • 2019 International Congress

    The relationship between constipation and alteration of gut microbiota in patients with Parkinson’s disease

    BI. Zao An, M. Ye (Nanjing, China)

    Objective: To  study compositional and functional differences  in the gut microbiota  and its products between  individuals with PD and matched controls,and these differences  are  or…
  • 2019 International Congress

    Sustained release triple drug loaded Microbaloons for management of Parkinson’s Disease

    S. Bhargava (Prayagraj, India)

    Objective: It is hypothesized that a drug delivery system that provides controlled and sustained release of PD drugs would afford better management of PD. Hollow…
  • 2019 International Congress

    Predicting the impact of Parkinson’s disease on a patient’s gait: the potential of innovative approaches based on instrumented clinical tests

    K. Lebel, C. Duval, E. Goubault, S. Bogard (Montréal, QC, Canada)

    Objective: To investigate the potential to predict the impact of the patient’s symptomatology on his ability to walk. Specifically, we (1) formed clusters of performance…
  • 2019 International Congress

    Approaches to assessing of disorders of voluntary posture control in patients with Parkinson’s disease

    A. Buniak, I. Maryenko, S. Likhachev, O. Alenikova (Minsk, Belarus)

    Objective: To assess disorders of VPC using the characteristics of the speed of voluntary movements in patients with PD. Background: At the advanced stage of…
  • 2019 International Congress

    Effects of an intensive rehabilitation program (SIROCCO) on prefrontal activity during walking in patients with Parkinson Disease

    I. Hoang, M. Ranchet, M. Cheminon, R. Derollepot, H. Devos, S. Perrey, J. Luauté, L. Paire-Ficout, T. Danaila (Bron, France)

    Objective: To investigate the effects of a 5-weeks intensive rehabilitation program on prefrontal activation during walking in patients with Parkinson Disease (PD). Background: Several studies…
  • « Previous Page
  • 1
  • …
  • 209
  • 210
  • 211
  • 212
  • 213
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley